MAZHAR GOLEWALE: Open Payments
NPI 1104048446 · OAKBROOK TERRACE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$43,532 in 133 payments from 22 companies in 2025. Trend: 2023 $816 · 2024 $11,058 · 2025 $43,532
Speaker / faculty: $32,370Consulting: $6,938Food & beverage: $3,504Travel & lodging: $721
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 31 | $27,409 |
| ABBVIE INC. | 22 | $14,331 |
| Eisai Inc. | 2 | $234 |
| E.R. Squibb & Sons, L.L.C. | 9 | $181 |
| Janssen Pharmaceuticals, Inc | 10 | $179 |
| Neurocrine BioSciences, Inc. | 9 | $169 |
| Otsuka America Pharmaceutical, Inc. | 9 | $146 |
| Supernus Pharmaceuticals, Inc. | 6 | $122 |
| Noven Therapeutics, LLC | 6 | $122 |
| Collegium Pharmaceutical, Inc. | 4 | $100 |
Products named: CAPLYTA, VRAYLAR, Leqembi, COBENFY, SPRAVATO, INGREZZA, REXULTI, Qelbree.
Industry payments across IL — which companies pay providers there.
